Works matching IS 2160763X AND DT 2014 AND VI 3 AND IP 4
Results: 13
A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 314, doi. 10.1002/cpdd.74
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. i, doi. 10.1002/cpdd.67
- Publication type:
- Article
Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 290, doi. 10.1002/cpdd.89
- By:
- Publication type:
- Article
Drug interactions with methadone: Time to revise the product label.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
A semi-mechanistic model to characterize the pharmacokinetics and pharmacodynamics of brodalumab in healthy volunteers and subjects with psoriasis in a first-in-human single ascending dose study.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 276, doi. 10.1002/cpdd.103
- By:
- Publication type:
- Article
A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal women.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 262, doi. 10.1002/cpdd.102
- By:
- Publication type:
- Article
A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 284, doi. 10.1002/cpdd.113
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of guanfacine extended release in adolescents aged 13-17 years with attention-deficit/hyperactivity disorder.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 252, doi. 10.1002/cpdd.124
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase-4 inhibitor.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 297, doi. 10.1002/cpdd.87
- By:
- Publication type:
- Article
Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 270, doi. 10.1002/cpdd.112
- By:
- Publication type:
- Article
Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 321, doi. 10.1002/cpdd.123
- By:
- Publication type:
- Article
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 328, doi. 10.1002/cpdd.86
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β<sub>2</sub>-agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 305, doi. 10.1002/cpdd.105
- By:
- Publication type:
- Article